Recursion Pharma Shares Sell-Off Signals Insider Uncertainty Amid Low Stock Price
Recursion Pharmaceuticals sells 200k shares as insider Gibson divests amid a $3.72 stock price and negative P/E, highlighting investor uncertainty and a tech‑driven biotech pivot.
2 minutes to read